Clinical year in review I: lung cancer, interventional pulmonology, noninvasive mask ventilation, and pulmonary vascular disease.
Trow
Terence K
TK
Winthrop-University Hospital, Mineola, New York, USA.
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism / Q000628:therapy*; D066246:ErbB Receptors / Q000187:drug effects / Q000235:genetics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology / Q000628:therapy*; D008171:Lung Diseases / Q000503:physiopathology / Q000628:therapy; D008175:Lung Neoplasms / Q000378:metabolism / Q000628:therapy*; D008397:Masks; D011655:Pulmonary Embolism / Q000503:physiopathology / Q000628:therapy*; D012121:Respiration, Artificial; D018084:Ultrasonography, Interventional; D014652:Vascular Diseases / Q000503:physiopathology / Q000628:therapy; D014655:Vascular Resistance
D000970:Antineoplastic Agents; D066246:ErbB Receptors